Julie Kelly

Julie Kelly is an accomplished professional in clinical quality assurance with extensive experience across multiple organizations. Currently serving as Associate Director of Clinical Quality Assurance at Corcept Therapeutics since July 2022, Julie has held similar leadership roles at Nordic Nanovector ASA and NuCana plc, where responsibilities included oversight of quality management systems and ensuring compliance with cGxP regulations. Previous positions include senior management and auditing roles at Medpace, Ockham, and TMQA, where Julie focused on developing audit teams and implementing quality assurance strategies. Julie began a career in quality assurance by conducting audits in pre-clinical settings and has a solid foundation in forensic and analytical chemistry, holding an MSci degree from the University of Strathclyde.